Oct 19 (Reuters) - Txcell SA TXCL.PA :
* Says together with University of British Columbia starts collaboration to develop CAR-tregs in solid organ transplantation
* Collaboration agreement covers development of a CAR-treg-based cellular immunotherapy for prevention of graft rejection in context of solid organ transplantation (SOT) Source text for Eikon: ID:nBw38DdQHa Further company coverage: TXCL.PA
(Gdynia Newsroom)